ClinConnect ClinConnect Logo
Search / Trial NCT06485310

Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients with a Primary Malignancy of the Central Nervous System

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA RÉUNION · Jun 26, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the impact of teleconsultations with a nurse who specializes in psychological support for patients diagnosed with a primary malignant tumor in the central nervous system. The goal is to see if these virtual meetings can help reduce psychological distress compared to standard care alone. Participants will be divided into two groups: one group will receive regular care plus the teleconsultation, while the other group will only receive the usual care. Throughout the study, participants will fill out questionnaires to assess their quality of life, anxiety, and social support at different points in time.

To join the trial, individuals must be at least 18 years old, have a confirmed diagnosis of a primary malignant brain tumor, and experience psychological distress. They should also have access to a computer or smartphone with a camera and microphone and be able to communicate in French. Participants will complete some initial questionnaires, have a teleconsultation with the nurse, and then follow up with more questionnaires and interviews at home if they choose. This study aims to provide valuable insights into how psychological support can help patients during a challenging time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged 18 and over
  • being treated for a primary malignant tumor of the central nervous system (positive biopsy)
  • with a Mini-Mental State score greater than 24
  • not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery)
  • with a distress score above 3 on the Psychological Distress Thermometer
  • have access to computer equipment equipped with a microphone and webcam (smartphone, computer)
  • able to read, write and speak French
  • have given free and informed consent
  • being affiliated to a social security scheme
  • Exclusion Criteria:
  • with a history of psychiatric illness
  • with recurrent cancer of the cerebral nervous system
  • having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care)
  • under guardianship, curatorship or deprived of liberty

About Centre Hospitalier Universitaire De La Réunion

The Centre Hospitalier Universitaire de la Réunion (CHU Réunion) is a leading academic medical center located on the island of Réunion. As a prominent clinical trial sponsor, CHU Réunion is dedicated to advancing medical research and improving patient care through innovative therapeutic studies and collaborations. With a focus on multidisciplinary approaches, the institution leverages its expertise in various medical fields to address pressing health challenges, enhance clinical practices, and promote evidence-based medicine. CHU Réunion is committed to ensuring patient safety and ethical standards in all research endeavors, contributing to the global body of medical knowledge.

Locations

St Pierre, Reunion, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported